Emergent BioSolutions Inc
EBS5.820USD
+0.190+3.37%
交易中 （美东）报价延迟15分钟
317.18M总市值
亏损市盈率 TTM
关于 Emergent BioSolutions Inc 公司
Emergent BioSolutions, Inc. 是一家生命科学公司。该公司专注于提供应对意外、故意和自然发生的公共卫生威胁的准备和响应解决方案。其解决方案包括产品组合、产品开发组合和生物服务组合。其部门包括商业产品、MCM 产品和服务部门。商业产品部门包括 NARCAN（盐酸纳洛酮）。MCM 产品部门包括炭疽 - MCM、天花 - MCM 和其他产品。服务部门包括其生物服务产品。NARCAN（盐酸纳洛酮）鼻喷雾剂是一种纳洛酮鼻腔制剂，用于紧急治疗已知或疑似阿片类药物过量，表现为呼吸和/或中枢神经系统抑制。其生物服务组合由三个相互关联的服务支柱组成，例如开发服务（工艺和分析开发）和药物物质制造。
公司简介
公司代码EBS
公司名称Emergent BioSolutions Inc
上市日期Nov 15, 2006
CEOMr. Joseph C. (Joe) Papa
员工数量900
证券类型Ordinary Share
年结日Nov 15
公司地址300 Professional Dr
城市GAITHERSBURG
上市交易所NYSE Consolidated
国家United States of America
邮编20879
电话12406313200
网址https://emergentbiosolutions.com/
公司代码EBS
上市日期Nov 15, 2006
CEOMr. Joseph C. (Joe) Papa
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
85.27K
+67.63%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
68.39K
+1061.66%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
68.25K
+101.64%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
66.14K
-10.60%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+21.24%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
201.49K
-1.34%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
121.47K
-1.02%
The Hon. Dr. Louis W. Sullivan, M.D.
The Hon. Dr. Louis W. Sullivan, M.D.
Independent Director
Independent Director
118.86K
+40.74%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+49.80%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
91.98K
+211.99%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
地区USD
名称
营收
占比
Non-U.S Government
143.40M
64.54%
U.S.Government
78.80M
35.46%
业务
地区
业务USD
名称
营收
占比
MCM Product sales
156.60M
70.48%
Commercial Product sales
45.30M
20.39%
Contracts and grants
20.30M
9.14%
股东统计
更新时间: 5月22日 周四
更新时间: 5月22日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
持股股东
持股股东
占比
The Vanguard Group, Inc.
5.92%
Millennium Management LLC
4.61%
American Century Investment Management, Inc.
4.23%
State Street Global Advisors (US)
3.15%
Dimensional Fund Advisors, L.P.
2.94%
Other
79.14%
股东类型
持股股东
占比
Investment Advisor
26.89%
Investment Advisor/Hedge Fund
20.51%
Hedge Fund
14.34%
Research Firm
4.30%
Individual Investor
3.04%
Pension Fund
1.04%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.17%
Venture Capital
0.16%
Other
28.88%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
443
38.62M
71.16%
-7.77M
2025Q1
472
38.22M
70.45%
-8.61M
2024Q4
475
36.31M
66.90%
-8.91M
2024Q3
485
33.46M
61.86%
-11.26M
2024Q2
503
32.16M
60.76%
-21.31M
2024Q1
512
37.52M
71.59%
-17.68M
2023Q4
531
43.49M
83.79%
-11.00M
2023Q3
581
43.88M
84.66%
-15.71M
2023Q2
596
48.59M
93.79%
-8.52M
2023Q1
682
47.08M
93.36%
-12.05M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
3.21M
5.92%
+13.30K
+0.42%
Mar 31, 2025
Millennium Management LLC
2.50M
4.61%
+1.02M
+68.87%
Mar 31, 2025
American Century Investment Management, Inc.
2.30M
4.23%
+159.91K
+7.48%
Mar 31, 2025
State Street Global Advisors (US)
1.71M
3.15%
-253.01K
-12.88%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.60M
2.94%
+492.58K
+44.62%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.58M
2.92%
-61.06K
-3.71%
Mar 31, 2025
Marshall Wace LLP
1.16M
2.13%
-170.78K
-12.85%
Mar 31, 2025
Palisade Capital Management, LLC
1.14M
2.1%
+202.86K
+21.61%
Mar 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.05%
--
--
Mar 31, 2025
Qube Research & Technologies Ltd
1.09M
2%
+271.55K
+33.29%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Harbor Human Capital Factor US Small Cap ETF
0.15%
Invesco RAFI US 1500 Small-Mid ETF
0.14%
SPDR S&P Biotech ETF
0.13%
Federated Hermes MDT Small Cap Core ETF
0.1%
Pacer US Small Cap Cash Cows ETF
0.09%
iShares Micro-Cap ETF
0.08%
Avantis US Small Cap Value ETF
0.08%
Direxion Daily S&P Biotech Bull 3X Shares
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Avantis US Small Cap Equity ETF
0.04%
查看更多
Harbor Human Capital Factor US Small Cap ETF
占比0.15%
Invesco RAFI US 1500 Small-Mid ETF
占比0.14%
SPDR S&P Biotech ETF
占比0.13%
Federated Hermes MDT Small Cap Core ETF
占比0.1%
Pacer US Small Cap Cash Cows ETF
占比0.09%
iShares Micro-Cap ETF
占比0.08%
Avantis US Small Cap Value ETF
占比0.08%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.05%
Avantis US Small Cap Equity ETF
占比0.04%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
